Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
Report ID | 189373 |
Drug Identification Number | 02433443 |
Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
Common or Proper name | Nystatin Oral Suspension USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 500 |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-12 |
Estimated end date | 2025-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-03-03 |
Company comments | Format 100 available. Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v35 | 2025-03-03 | French | Compare |
v34 | 2025-03-03 | English | Compare |
v33 | 2025-01-04 | French | Compare |
v32 | 2025-01-04 | English | Compare |
v31 | 2024-11-01 | French | Compare |
v30 | 2024-11-01 | English | Compare |
v29 | 2024-11-01 | French | Compare |
v28 | 2024-11-01 | English | Compare |
v27 | 2024-09-04 | French | Compare |
v26 | 2024-09-04 | English | Compare |
v25 | 2024-07-29 | French | Compare |
v24 | 2024-07-29 | English | Compare |
v23 | 2024-07-03 | French | Compare |
v22 | 2024-07-03 | English | Compare |
v21 | 2024-03-11 | French | Compare |
v20 | 2024-03-11 | English | Compare |
v19 | 2024-03-04 | French | Compare |
v18 | 2024-03-04 | English | Compare |
v17 | 2023-12-18 | French | Compare |
v16 | 2023-12-18 | English | Compare |